| Literature DB >> 23791620 |
Daniel E Kadouri1, Robert M Q Shanks.
Abstract
In this study, we identified an antimicrobial compound produced by the Gram-negative bacterium Serratia marcescens. Colonies of S. marcescens inhibited the growth of nine different methicillin-resistant Staphylococcus aureus (MRSA) isolates and several other tested Gram-positive bacterial species, but not Gram-negative bacteria. Genetic analysis revealed the requirement for the swrW gene which codes for a non-ribosomal peptide synthetase that generates the cyclodepsipeptide antibiotic serratamolide, also known as serrawettin W1. This is the first report describing the anti-MRSA properties of serratamolide.Entities:
Keywords: Aminolipid; Antibiotic; MRSA; Non-ribosomal peptide synthetase; Nosocomial infection; Secondary metabolite
Mesh:
Substances:
Year: 2013 PMID: 23791620 PMCID: PMC3770767 DOI: 10.1016/j.resmic.2013.06.002
Source DB: PubMed Journal: Res Microbiol ISSN: 0923-2508 Impact factor: 3.992